Exploring Low-Dose Naltrexone in Cancer Treatment - Dr Nasha Winters

Low-dose naltrexone (LDN) is highlighted as a supportive treatment in oncology, enhancing other therapies rather than acting alone. It helps regulate the immune system, calms microglia, and alleviates symptoms like pain and fatigue. LDN's low toxicity and potential to improve quality of life are emphasized, along with its evolving role in cancer therapies and immune modulation.